Medical Care Technologies Expands StrainScan Pro into Agriculture
Analysis based on 38 articles · First reported Aug 05, 2026 · Last updated Aug 21, 2026
The announcement may generate speculative interest in MDCE's stock as it positions its AI technology in large addressable markets, but lacks concrete commercial traction. The impact is likely limited given the absence of revenue forecasts or customer commitments.
Medical Care Technologies Inc. Inc. (OTC Pink:MDCE) has launched and is expanding its proprietary AI vision platform, StrainScan Pro, initially focused on cannabis strain identification for dispensaries, into agricultural quality control and food supply chain monitoring. The platform, deployable on iPad Air devices, provides on-device visual analysis for strain consistency, potency-related visual indicators, early pest and crop illness detection, and freshness tracking from field to retail. The company targets the multi-trillion-dollar global agriculture market, estimated near $5 trillion, and the multi-billion-dollar cannabis retail sector. CEO Marshall Perkins emphasized the platform's scalability and enterprise positioning. The company continues to generate revenue through subsidiaries Infinite Auctions and Real Game Used. No specific revenue targets or customer deployments were disclosed.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard